Pharmaceuticals and Biotech IMS Health forecasts worldwide pharmaceutical sales to increase 4.5%–5.5% this year, on par with 2008, to more than $820 billion (see IBO 10/31/08). The substantial cash holdings of major pharmaceutical companies could increase M&A activities. The target of these acquisitions are expected to be smaller biotech firms that are unable to access […]

As a regular feature of our annual forecast issue, IBO selects a firm from our industry as “company of the year.” In designating the company of the year, IBO recognizes an analytical or life science instrument maker that has accomplished technical, operational and financial achievements. Such achievements are a function of strong financial performance, market […]

Illkirch Cedex, France 1/5/09—Chiral Technologies Europe, a wholly owned subsidiary of Daicel Chemical Industries that supplies phases, columns and services for enantioselective chromatography, has acquired ChromTech. Based in Congleton, UK, ChromTech provides protein-based columns for reversed-phase HPLC in three phases. “ChromTech’s specialty line of protein-based columns adds a complimentary product range to our Daicel polysaccharide-based […]

The set use of many atomic spectroscopy techniques for legally mandated environmental analysis applications should help to insulate the sector from the negative effects of the global economy. The continuing international interest in green technologies and environmental safety should also remain strong sources of growth in demand for atomic spectroscopy. The techniques most associated with […]

While the overall MS market did not quite match the growth initially expected for 2008 (see IBO 1/5/08), it grew more than 8% in the past year. Despite the severe global recession, IBO expects the demand for MS to grow 7.7% in 2009, which will easily put the total market value over the $2.5 billion […]

Financial Crisis As with firms worldwide, analytical and life science instrument companies found themselves at the mercy of the credit crisis, failing stock markets and lower industrial demand at year-end. Some of the strongest markets for instrumentation in recent years—the petrochemical, metals and chemical industries—abruptly slowed operations in late 2008 and announced cost cuts for […]

Growth in 2008 for the separations market was nearly two percentage points lower than the original forecast estimates (see IBO 1/15/08) due, in part, to the weakened third and fourth quarters marked by the global financial crisis. In 2008, the separations market accounted for $6.6 billion in revenues and grew 6.6% over 2007. For 2009, […]

According to the Organization for Economic Cooperation and Development (OECD), the US subprime mortgage crisis has spread to many nonfinancial sectors and has had widespread negative effects on world economies. In comparison to the 1.4% GDP increase for 2008, OECD countries’ GDP will decline by 0.4% for 2009. In the November update of the International […]

San Diego, CA and Oxford, UK 1/11/09—Illumina and Oxford Nanopore Technologies announced a strategic alliance to develop and sell single-molecule DNA sequencing technology. Under a commercialization agreement, Illumina will exclusively market, sell, distribute and service Oxford Nanopore’s BASE Technology products into the research and diagnostic markets. The companies will share profits from the sales. Illumina […]

GE Purchases Whatman The acquisition (see IBO 2/15/08) was evidence that GE Life Science is still intent on growing its business. The $713 million purchase was also a testament to the importance of sample preparation products to life science suppliers. Agilent Expands Materials Science Business Four acquisitions this year (see IBO 3/15/08, 6/30/08, 7/15/08) added […]